Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Hyperfine, Inc. (HYPR : NSDQ)

• Company Description    Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn. Number of Employees: 102

• Price / Volume Information    Yesterday's Closing Price: $0.72 Daily Weekly Monthly 20 Day Moving Average: 1,256,404 shares Shares Outstanding: 106.05 (millions) Market Capitalization: $76.82 (millions) Beta: 1.45 52 Week High: $1.94 52 Week Low: $0.70 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.93% -9.53% 12 Week -22.59% -23.95% Year To Date -26.03% -33.58%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 351 NEW WHITFIELD STREET - GUILFORD,CT 06437 USA ph: 866-796-6767 fax: - webb@gilmartinir.com https://hyperfine.io

• General Corporate Information    Officers Maria Sainz - Chief Executive Officer; President and Director Daniel J. Wolterman - Chairperson of the Board Thomas Teisseyre - Chief Operating Officer Brett Hale - Chief Administrative Officer; Chief Financial Offi John Dahldorf - Director Peer Information Hyperfine, Inc. (ABMD) Hyperfine, Inc. (DMDS) Hyperfine, Inc. (CPWY.) Hyperfine, Inc. (EQUR) Hyperfine, Inc. (ECIA) Hyperfine, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 44916K106 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/09/26 Share - Related Items Shares Outstanding: 106.05 Most Recent Split Date: (:1) Beta: 1.45 Market Capitalization: $76.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.34 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/09/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.09 Price/Cash Flow: - Price / Sales: 4.65 EPS Growth vs. Year Ago Period: 25.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 44.81% vs. Previous Quarter: 0.03% ROE 09/30/26 - - 06/30/26 - -97.88 03/31/26 - -98.83 ROA 09/30/26 - - 06/30/26 - -61.81 03/31/26 - -67.09 Current Ratio 09/30/26 - - 06/30/26 - 6.15 03/31/26 - 5.52 Quick Ratio 09/30/26 - - 06/30/26 - 5.45 03/31/26 - 4.90 Operating Margin 09/30/26 - - 06/30/26 - -205.68 03/31/26 - -221.41 Net Margin 09/30/26 - - 06/30/26 - -210.75 03/31/26 - -226.88 Pre-Tax Margin 09/30/26 - - 06/30/26 - -210.75 03/31/26 - -226.88 Book Value 09/30/26 - - 06/30/26 - 0.35 03/31/26 - 0.35 Inventory Turnover 09/30/26 - - 06/30/26 - 1.23 03/31/26 - 1.24 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.36 03/31/26 - 0.38 Debt-to-Capital 09/30/26 - - 06/30/26 - 26.47 03/31/26 - 27.64

Powered by Zacks Investment Research ©